Funded Startups in Gaithersburg
Disclosed round sizes in Gaithersburg are led by Remedy Plan Therapeutics, which raised $18M on 2025-05-13.
Disclosed round sizes in Gaithersburg are led by Remedy Plan Therapeutics, which raised $18M on 2025-05-13. That $18M stands out against the next visible upper range—Robotic Research’s $75M (2024-09-10) and Cartesian Therapeutics’ $130M (2024-07-02) and Arcellx’s $100M (2022-12-09) and others—so the list is marked by a few high-dollar exceptions rather than a steady climb.
The 19 entries span 2020-09-09 (Xometry) through 2025-08-26 (Polaris Genomics), with multiple biotech-heavy clusters. Biotech appears across 9 of the 19 rows, while 11 of 19 entries are labeled “Series Unknown” and 2 of 19 are explicitly “undisclosed” on amounts (Certify Health on 2025-05-13 and Euclid TechLabs on 2023-08-16), limiting stage comparisons. Date-wise, there’s a tight May 2025 cluster (Polaris Genomics 2025-08-26; Certify Health and Remedy Plan Therapeutics both 2025-05-13; Silvec Biologics 2025-06-10; HeMemics 2025-03-19), and the city field consistently stays as Gaithersburg, Maryland across the rows.
Most recent rounds
19 shownRelated listings
Frequently asked
What round sizes stand out in Gaithersburg, and how do they compare to the rest of the disclosed amounts?
Cartesian Therapeutics’ $130M (2024-07-02) is the largest disclosed amount in the list, substantially above the next-high values like Robotic Research’s $75M (2024-09-10) and Georgiamune’s $75M (2023-08-09). Several other disclosed rounds cluster in much lower bands, such as $250K for Polaris Genomics (2025-08-26) and HeMemics Biotechnologies (2025-03-19), and $400K for Givhero (2023-03-22).
Is there a dense time window where multiple funding rounds land, or are the rounds evenly spread?
The rounds are not evenly spread: multiple entries concentrate in the 2023–2024 period (e.g., Robotic Research $75M on 2024-09-10; Cartesian Therapeutics $130M on 2024-07-02; Sirnaomics $8M on 2024-10-04) and again in mid-2025 (Certify Health and Remedy Plan Therapeutics both on 2025-05-13, with Remedy Plan Therapeutics showing $18M). The oldest visible round is Xometry on 2020-09-09, while the most recent is Polaris Genomics on 2025-08-26.
Which sectors are over-represented, and do biotech and other categories dominate differently by count?
Biotechnology dominates by count, appearing in 9 of the 19 rows (including Remedy Plan Therapeutics 2025-05-13 and Arcellx 2022-12-09). Other sectors appear less frequently: Hardware (Robotic Research on 2024-09-10) and Manufacturing (Euclid TechLabs, 2023-08-16) each show up once in this view, while Agriculture and Farming (Silvec Biologics, 2025-06-10) also appears once.
How should stage interpretation be handled given the number of 'Series Unknown' and 'undisclosed' outcomes?
Stage signals are limited: 11 of 19 rows list “Series Unknown,” and 2 of 19 rows have amounts marked “undisclosed” (Certify Health on 2025-05-13 and Euclid TechLabs on 2023-08-16). That makes cross-stage comparisons harder than a dataset with mostly labeled stages and disclosed dollar amounts.
Are there notable outliers that combine large disclosed rounds with specific stages or categories?
Yes. Cartesian Therapeutics shows an extreme disclosed amount ($130M on 2024-07-02) while being categorized as Biotechnology with “Series Unknown,” and Arcellx ($100M on 2022-12-09) is also Biotechnology with “Series Unknown.” In contrast, several biotech entries are far smaller on disclosed amounts (e.g., $2M for Amplexd Therapeutics on 2024-05-20 and $3M for TeraImmune on 2022-12-22), suggesting strong dispersion within the same sector label.
Which entries in this list fall into the most recent timeframe shown, and do they share similar sector or amount patterns?
Within the most recent year range in the data, entries include Polaris Genomics ($250K, 2025-08-26) and Silvec Biologics ($100K, 2025-06-10), plus the mid-May 2025 pair of Certify Health (undisclosed, 2025-05-13) and Remedy Plan Therapeutics ($18M, 2025-05-13). Sector-wise, biotech is represented in that recent set (Certify Health and Remedy Plan Therapeutics), but disclosed amounts vary widely from six-figure rounds to the $18M shown by Remedy Plan Therapeutics.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.